×

Our award-winning reporting has moved

Context provides news and analysis on three of the world’s most critical issues:

climate change, the impact of technology on society, and inclusive economies.

Drug resistance in people and animals may push millions into poverty - World Bank

by Alex Whiting | @AlexWhi | Thomson Reuters Foundation
Monday, 19 September 2016 12:07 GMT

The rise of "superbugs" resistant to drugs has been caused partly by the increased use and misuse of antibiotics and other antimicrobial drugs

By Alex Whiting

ROME, Sept 19 (Thomson Reuters Foundation) - If drug-resistant infections in people and animals are allowed to spread unchecked, some 28 million people will fall into poverty by 2050, and a century of progress in health will be reversed, the World Bank said on Monday.

By 2050, annual global GDP would fall by at least 1.1 percent, although the loss could be as much as 3.8 percent - the equivalent of the 2008 financial crisis - the Bank said in a report released ahead of a high-level meeting on the issue at the United Nations in New York this week.

The rise of "superbugs" resistant to drugs has been caused partly by the increased use and misuse of antibiotics and other antimicrobial drugs in the treatment of people and in farming.

"We cannot afford to lose the gains in the last century brought about by the antibiotic era," Tim Evans, the World Bank's senior director for health, nutrition and population, told the Thomson Reuters Foundation.

"By any measure, the cost of inaction on antimicrobial resistance is too great, it needs to be addressed urgently and resolutely," he said.

Greater quantities of antibiotics are used in farming than for treating people, and much of this is for promoting animal growth rather than treating sick animals, economist Jim O'Neill said in a report in May commissioned by the British government.

The O'Neill report estimated that drug-resistant infections could kill more than 10 million people a year by 2050, up from half a million today, and the costs of treatment would soar.

LIVESTOCK

Farmers too will be greatly affected. The bank estimates that by 2050, global livestock production could fall by between 2.6 percent and 7.5 percent a year, if the problem of drug resistant superbugs is not curbed.

"Investments are urgently needed to establish basic veterinary public health capacities in developing countries," Evans said.

Improved disease surveillance, diagnostic laboratories to ensure a disease is identified quickly, inspections of farms and slaughterhouses, training of vets, and oversight over the use of antibiotics are also needed, he said.

The U.N. Food and Agriculture Organization (FAO) estimates 60,000 tonnes of antimicrobials are used in livestock each year, a number set to rise with growing demand for animal products.

One of the most important ways to curb the spread of drug resistant microbes in food is to promote good farming practices, said Juan Lubroth, chief veterinary officer of FAO.

"I think this is where we can do most of our prevention - better knowledge on hygiene, vaccination campaigns, so these animals do not get sick and need antimicrobials (drugs)," Lubroth said in an interview from Rome.

Public demand for food that is uncontaminated, and better training of health professionals - doctors and vets - are also vital to help contain the problem, he added.

Hospitals and pharmaceutical companies also need to do more to treat their waste, he said.

The World Bank estimates that an investment of some $9 billion a year is needed in veterinary and human health to tackle the issue.

"The expected return on this investment is estimated to be between $2 trillion and $5.4 trillion ... or at least 10 to 20 times the cost, which should help generate political will necessary to make these investments," Evans said.

(Reporting by Alex Whiting, Editing by Ros Russell.; Please credit the Thomson Reuters Foundation, the charitable arm of Thomson Reuters, that covers humanitarian news, women's rights, trafficking, corruption and climate change. Visit http://news.trust.org)

Our Standards: The Thomson Reuters Trust Principles.

-->